Creation of new nanostructures possessing high antitumor activity is an important problem of modern biotechnology. Aim. To evaluate cytotoxicity of created complex of pristine C 60 fullerene with the anthracycline antibiotic doxorubicin (Dox), as well as of free C 60 fullerene and Dox, towards different cell types-tumor, normal immunocompetent and hepatocytes. Methods. Measurement of size distribution for particles in C 60 + Dox mixture was performed by a dynamic light scattering (DLS) technique. Toxic effect of C 60 + Dox complex in vitro towards tumor and normal cells was studied using the MTT assay. Results. DLS experiment demonstrated that the main fraction of the particles in C 60 + Dox mixture had a diameter in the range of about 132 nm. The toxic effect of C 60 + Dox complex towards normal (lymphocytes, macrophages, hepatocytes) and tumor (Ehrlich ascites carcinoma, leukemia L1210, Lewis lung carcinoma) cells was decreased by~10-16 % and~7-9 %, accordingly, compared with the same effect of free Dox. Conclusions. The created C 60 + Dox composite may be considered as a new pharmacological agent that kills effectively tumor cells in vitro and simultaneously prevents a toxic effect of the free form of Dox on normal cells.